BioBlog Weekly: Oncology Patient Advocacy Spotlight
This week’s oncology patient advocacy spotlight: JAMA article shows large clinical trial disparities among lower income patients with cancer, typical silver health plans’ out of pocket expenses are twice as high as in average employer plans, and the importance of teaching American consumers how to use their health insurance.
A new study published in JAMA Oncology has found that “newly diagnosed cancer patients with an annual income of less than $50,000 are 32% less likely to participate in clinical trials than patients with incomes over $50,000.”
Out-of-Pocket Prescription Costs Under a Typical Silver Plan are Twice as High as They Are in the Average Employer Plan
This study found that “out-of-pocket expenses for medications in a typical silver plan are twice as high as they are in the average employer-sponsored plan, resulting in fewer prescriptions filled and refilled and in higher spending on other medical services.” The study also argues that “maintaining the use of cost-effective prescription medications might require lower cost sharing for patients with chronic conditions than is currently found in the Marketplaces.”
This article argues the value of personal engagement for patients: “a person is so much more than their condition or disease. They are people. They are moms and dads. They are caregivers. They are professionals, unemployed, and retired. They have fears and dreams. They have names. …health is more than any one thing, it’s about a person’s total life and social context as well the injury or illness they are battling.”
Multiple articles have found that “only about half of those surveyed could correctly figure out what they would need to pay in out-of-pocket cost for a hospital stay when given the deductible and the co-pay.”
The articles above are from our dedicated Oncology Patient Advocacy e-magazine. You can follow us on Flipboard or Twitter, or just watch for the links to this and our other magazines in our regular weekly BioBlog emails. (Don’t get our emails yet? Subscribe here!)